Join the conversation

Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Loading...Loading...Loading...Loading...

Trending Tickers

SLS logo
Top trending tickerSLS
$8.43
7.24%
#1
SELLASs Phase 3 REGAL trial results for galinpepimut-S (GPS) in AML are the focus after the trial reached the death-event threshold for final analysis, with topline results expected this month. Traders are divided on the outcome, and unusual trading activity has fueled unconfirmed leak and short-covering speculation, while others caution that the trial remains a binary risk.
INFQ logo
INFQ
$8.05
5.07%
#2
INFQ is drawing attention amid a sharp selloff shared by quantum and other speculative small-cap tech stocks; traders debate whether broad risk-off pressure and forced selling are driving the decline or whether the stocks earnings miss and widening losses signal company-specific concerns. Bulls point to its cash position, maintained revenue guidance, and technical milestones as reasons to stay focused on long-term execution, while others warn that the price could fall further.
UAL logo
UAL
$109.31
0.00%
#3
A reported widespread United system outage disrupting departing flightsfollowing a recent FAA communications failure and nationwide ground stopis driving concern about operational disruption. Traders debate whether the setback is a buying opportunity or another reason for caution; cyberattack claims remain speculation, with some posts describing it as a technical glitch.
OMER logo
OMER
$15.69
10.29%
#4
Omeross latest quarterly results showed continued YARTEMLEA sales growth and positive operating cash flow, but the shares sold off after the report. Traders are split between seeing strong launch momentum and a positive outlook versus arguing expectations were higher and focusing on the GAAP loss and funding concerns.
CAPR logo
CAPR
$8.14
14.59%
#5
Capricors pending FDA decision on Deramiocel for Duchenne muscular dystrophy is driving intense attention, with the recent Summit rejection amplifying concern about a possible CRL. Traders are split over whether HOPE-3s upper-limb results and amended application can overcome regulatory skepticism tied to the prior rejection and advisory-panel concerns, alongside debate about institutional selling.
BAC logo
BAC
$50.02
1.96%
#6
Reported online-banking disruptions at Bank of America and several other major banks are driving concern about customers ability to access accounts and transfer funds. Some traders speculate about cyberattacks or broader banking stress, but the cause of the disruptions is not established in the discussion.
NOK logo
NOK
$7.46
7.56%
#7
Nokias selloff is being attributed by traders to reports that Nvidia reduced its stake, alongside broader weakness in AI-linked stocks; the discussion is dominated by bearish reactions to the decline and worries about further losses. Some investors counter that Nokias AI-networking and telecom infrastructure exposure supports a longer-term case, but that optimism competes with concerns about weak price momentum.
JPM logo
JPM
$338.90
2.11%
#8
JPMorgans reported software issue delaying some customer transactions is drawing attention, with traders debating whether it is a technical glitch or a cyberattack; the bank has attributed the delays to a software bug and said there is no evidence of an attack. The outage chatter coincides with pressure on bank shares and a weaker broader market, while some traders expect service to normalize.
HELP logo
HELP
$7.54
15.01%
#9
Helus Pharmas HLP003 met its primary endpoint in a Phase 3 depression trial, but shares sold off as traders focused on three treatment-related serious adverse events, including a suicide attempt, and sought more safety detail. The community is split between viewing the efficacy as strong and the safety concerns as unresolved, with financing and dilution worries adding pressure.
SHAZ logo
SHAZ
$19.38
14.10%
#10
SharonAIs AI-infrastructure expansion, backed by large cloud contracts and a major strategic financing, is driving attention as it scales NVIDIA-powered data centers across Australia and the Asia-Pacific. Bulls point to institutional backing and contracted demand, while skeptics cite share dilution, execution risk, and sharp price swings.

About Stocktwits

With over 10 million users, Stocktwits helps you tap into the real-time sentiment and trending insights across stocks, ETFs, and crypto.